Syncom Healthcare Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Syncom Healthcare Limited generated cash of $0, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2010 | -179.61M | -81.90M | 419.74M |
|---|---|---|---|
| 2011 | -82.64M | -21.72M | 840.49M |
| 2012 | -1.99B | 58.15M | 1.04B |
| 2016 | -79.75M | 93.78M | -9.33M |
| 2018 | 56.53M | -9.67M | -48.46M |
| 2020 | -93.99K | 4.57M | -2.64M |
| 2021 | 24.22M | -30.71M | 5.07M |
| 2023 | 0 | 0 | 0 |
SYNCOM.NS Cash Flow Statement (2010 – 2022)
| 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 3.79M | 1.96M | 2.73M | 3.94M | 895.80M | 159.67M | 1.45M |
Operating activities | ||||||||
Net income | 0 | -49.09M | -117.18M | -782.35M | -34.31M | 33.45M | 26.28M | 37.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 19.92M | 22.91M | 37.38M | 41.47M | 23.22M | 18.35M | 18.89M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 905K | 175.87M | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 15.66M | 50.81M | 12.74M | -356.04K | -554.81M | -3.21M | -10.79M |
Accounts payable | 0 | -2.42M | -176.01M | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 0 | 24.22M | -93.99K | 56.53M | -79.75M | -1.99B | -82.64M | -179.61M |
Investing activities | ||||||||
Purchases Of Investments | 0 | -30.71M | -5.71M | 0 | 0 | -2.41M | 0 | -39.92M |
Investments In Property Plant And Equipment | 0 | 0 | -116K | -1.34M | -14.05M | -20.84M | -21.73M | -42.05M |
Acquisitions Net | 0 | 0 | 150K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -30.71M | 4.57M | -9.67M | 93.78M | 58.15M | -21.72M | -81.90M |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 2.41M | 225M | 75M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -5.07M | 0 | 0 | 0 | -44.87M | -231.06M | -425.90M |
Cash used in financing activities | 0 | 5.07M | -2.64M | -48.46M | -9.33M | 1.04B | 840.49M | 419.74M |
Net Change In Cash | 0 | 36.99M | 1.83M | -1.60M | 4.69M | -891.34M | 736.13M | 158.22M |
Cash at end of period | 0 | 40.79M | 3.79M | 1.13M | 8.64M | 4.46M | 895.80M | 159.67M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |